Poster Session: Public Health
Iwona Iwona Paradowska-Stankiewicz, Ph.D
National Institute of Public Health - NIH National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance,
Warsaw, Mazowieckie, Poland
Jakub Zbrzeźniak, Ph.D.
National Institute of Public Health - NIH National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance,
Warsaw, Mazowieckie, Poland
Jozica Skufca, Epidemiologist
P95
Leuven, Vlaams-Brabant, Belgium
Archana Nagarajan, Ph.D.
P95
Leuven, Vlaams-Brabant, Belgium
Paulina Ochocka, Manager
National Institute of Public Health - NIH National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance,
Warsaw, Mazowieckie, Poland
Andreas Pilz, PhD
Director
Pfizer Corporation Austria
Vienna, Wien, Austria
Andrew Vyse, Ph.D.
Pfizer UK
Tadworth, England, United Kingdom
Elizabeth Begier, M.D., M.P.H.
Pfizer Vaccines
Dublin, Dublin, Ireland
Mendwas Dzingina, Ph.D.
Pfizer UK
Tadworth, England, United Kingdom
Maxim Blum, Ph.D.
P95
Leuven, Vlaams-Brabant, Belgium
Margarita Riera, MD, MPH
P95
Leuven, Vlaams-Brabant, Belgium
Bradford Gessner, MD, MPH
Pfizer US
New York, New York, United States
James Stark, Ph.D.
Pfizer US
Collegeville, Pennsylvania, United States